Breaking out of the investor gloom
This article was originally published in Clinica
Executive Summary
Medtech companies should brace themselves for rough terrain ahead, as continued weakness in the economy and investor uncertainty spell a gloomy outlook. But planning for the long-term, among other safety measures, should enable your business to get through the hard times. Tina Tan finds out more at the MedTech Investing Europe conference